ReviewFree neuropathology2026
Forensic neuropathology: 2026 update.
Review in Free neuropathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review discusses key publications in forensic neuropathology from the 2025 literature. In abusive head trauma (AHT), biomechanical models help clarify injury mechanisms, particularly the role of sagittal angular acceleration in younger infants. However, challenges remain, such as detecting subtle brainstem pathology with neuroimaging, stressing the need for prospective clinicopathological correlation. Meanwhile, understanding of chronic traumatic encephalopathy (CTE) is expanding beyond contact sports to include victims of intimate partner violence. Research on sudden unexpected death in epilepsy (SUDEP) indicates overlaps with sudden infant death syndrome (SIDS) and identifies key risk factors. At the same time, forensic neuropathology's primary role remains the exclusion of other causes of death. Artificial intelligence shows promise for analyzing radiological and histopathological data in traumatic brain injury (TBI) and epilepsy, though its adoption for routine purposes remains a distant goal. Further developments include a better understanding of the cerebellum's vulnerability to TBI, standardized postmortem MRI protocols, and the use of cerebrospinal fluid biomarkers, such as GFAP and S100B, to estimate time of death. Finally, research continues to probe the complex links between brain morphology and behavior, and recent studies of the neuropathology of alcohol use disorder have revealed microglial changes rather than overt neuronal loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.